These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 28259898)

  • 41. Determination of the levels of anti-thyroid-stimulating hormone receptor antibody with thyroid peroxidase antibody in Omani patients with Graves' disease.
    Alnaqdy A; Al-Maskari M
    Med Princ Pract; 2005; 14(4):209-12. PubMed ID: 15961927
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Genetic linkages for thyroxine released in response to thyrotropin stimulation in three sets of recombinant inbred mice provide evidence for shared and novel genes controlling thyroid function.
    Hamidi S; Aliesky HA; Williams RW; Rapoport B; McLachlan SM
    Thyroid; 2013 Mar; 23(3):360-70. PubMed ID: 22988948
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Immunoglobulins of untreated Graves' patients with or without thyrotropin receptor antibody (determined by porcine thyrocytes) universally elicit potent thyroid hormone-releasing activity in cultured human thyroid follicles.
    Sato K; Yamazaki K; Yamada E; Kanaji Y; Miura M; Obara T
    Thyroid; 1999 Oct; 9(10):979-88. PubMed ID: 10560951
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Thyroid vascularization by color doppler ultrasonography in Graves' disease. Changes related to different phases and to the long-term outcome of the disease.
    Baldini M; Castagnone D; Rivolta R; Meroni L; Pappalettera M; Cantalamessa L
    Thyroid; 1997 Dec; 7(6):823-8. PubMed ID: 9459623
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The mechanisms of transient hypothyroxinemia in infants born to mothers with Graves' disease.
    Matsuura N; Harada S; Ohyama Y; Shibayama K; Fukushi M; Ishikawa N; Yuri K; Nakanishi M; Yokota Y; Kazahari K; Oguchi H
    Pediatr Res; 1997 Aug; 42(2):214-8. PubMed ID: 9262225
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Relationship between CTLA-4 and CD28 molecule expression on T lymphocytes and stimulating and blocking autoantibodies to the TSH-receptor in children with Graves' disease.
    Bossowski A; Stasiak-Barmuta A; Urban M
    Horm Res; 2005; 64(4):189-97. PubMed ID: 16220002
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antibody to gp39, the ligand for CD40 significantly inhibits the humoral response from Graves' thyroid tissues xenografted into severe combined immunodeficient (SCID) mice.
    Resetkova E; Kawai K; Enomoto T; Arreaza G; Togun R; Foy TM; Noelle RJ; Volpé R
    Thyroid; 1996 Aug; 6(4):267-73. PubMed ID: 8875745
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Induction of hyperthyroidism in mice by intradermal immunization with DNA encoding the thyrotropin receptor.
    Barrett K; Liakata E; Rao PV; Watson PF; Weetman AP; Lymberi P; Banga JP; Carayanniotis G
    Clin Exp Immunol; 2004 Jun; 136(3):413-22. PubMed ID: 15147342
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hyperthyroid monkeys: a nonhuman primate model of experimental Graves' disease.
    Wang Y; Wu LP; Fu J; Lv HJ; Guan XY; Xu L; Chen P; Gao CQ; Hou P; Ji MJ; Shi BY
    J Endocrinol; 2013 Dec; 219(3):183-93. PubMed ID: 24029729
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Antibodies against TSH receptors (TRAb) as indicators in prognosing the effectiveness of Tiamazol therapy for Grave's Disease].
    Bojarska-Szmygin A; Ciechanek R
    Wiad Lek; 2003; 56(7-8):303-7. PubMed ID: 14969154
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Immunization of mice with a newly identified thyroid-stimulating hormone receptor splice variant induces Graves'-like disease.
    Endo T; Kobayashi T
    J Autoimmun; 2013 Jun; 43():18-25. PubMed ID: 23538203
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [The role of circulating immune complexes in the pathogenesis of Graves' disease].
    Funauchi M
    Nihon Naibunpi Gakkai Zasshi; 1983 Dec; 59(12):1912-27. PubMed ID: 6325260
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Loss of integrity of thyroid morphology and function in children born to mothers with inadequately treated Graves' disease.
    Kempers MJ; van Trotsenburg AS; van Rijn RR; Smets AM; Smit BJ; de Vijlder JJ; Vulsma T
    J Clin Endocrinol Metab; 2007 Aug; 92(8):2984-91. PubMed ID: 17504907
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Similar clinical performance of a novel chimeric thyroid-stimulating hormone receptor bioassay and an automated thyroid-stimulating hormone receptor binding assay in Graves' disease.
    Kamijo K; Murayama H; Uzu T; Togashi K; Olivo PD; Kahaly GJ
    Thyroid; 2011 Dec; 21(12):1295-9. PubMed ID: 22066477
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Individual outcome monitoring of TSH receptor antibody level for predicting the prognosis of Graves' disease].
    Rink T; Holle LH; Schroth HJ; Garth H
    Nuklearmedizin; 1998 May; 37(3):90-4. PubMed ID: 9604228
    [TBL] [Abstract][Full Text] [Related]  

  • 56. TSH-receptor autoimmunity in Graves' disease after therapy with anti-thyroid drugs, surgery, or radioiodine: a 5-year prospective randomized study.
    Laurberg P; Wallin G; Tallstedt L; Abraham-Nordling M; Lundell G; Tørring O
    Eur J Endocrinol; 2008 Jan; 158(1):69-75. PubMed ID: 18166819
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prolonged TSH receptor A subunit immunization of female mice leads to a long-term model of Graves' disease, tachycardia, and cardiac hypertrophy.
    Holthoff HP; Goebel S; Li Z; Faßbender J; Reimann A; Zeibig S; Lohse MJ; Münch G; Ungerer M
    Endocrinology; 2015 Apr; 156(4):1577-89. PubMed ID: 25562617
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Characterization and clinical relevance of circulating CD4+CD28- T cells in Graves' disease.
    Wang F; Chen L; Shen Q; Liu T; Jiang L; Gu X; Chen L; Sun J; Liu C
    Immunol Lett; 2015 May; 165(1):47-51. PubMed ID: 25839128
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Regulation of intercellular adhesion molecule-1 expression in human thyroid cells in vitro and human thyroid tissue transplanted to the nude mouse in vivo: role of Graves' immunoglobulins and human thyrotropin receptor.
    Hoermann R; Spitzweg C; Poertl S; Mann K; Heufelder AE; Schumm-Draeger PM
    J Clin Endocrinol Metab; 1997 Jul; 82(7):2048-55. PubMed ID: 9215271
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Differential Susceptibility of BALB/c and BALB/cBy mice to Graves' hyperthyroidism.
    Seetharamaiah GS; Land KJ
    Thyroid; 2006 Jul; 16(7):651-8. PubMed ID: 16889488
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.